| Source | NBC Local |
|---|---|
| Original Load Date | Aug. 26, 2026, 5:01 p.m. |
| Last Updated | Aug. 26, 2026, 5:01 p.m. |
| Original URL | https://www.nbcchicago.com/news/local/how-2-chicago-hospitals-were-involved-with-game-changing-pancreatic-cancer-drug/3980839/ |
Article Preview
The Food and Drug Administration on Wednesday approved a groundbreaking
pancreatic cancer drug that experts predict will transform treatment for the
notoriously deadly disease.
The drug, Revolution Medicines' Rasonque, or daraxonrasib, was approved for
patients with advanced pancreatic cancer who h...